Benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel — RxCUI 244374
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Erythromycin and Benzoyl Peroxide Topical: what it is, how it’s used, side effects, and interactions.
- This gel is a prescription treatment for acne vulgaris — the everyday kind of acne that causes pimples, blackheads, and red inflamed spots. It combines two ingredients that work to...
- Apply it twice a day — once in the morning and once at night. Before you put it on, wash the area with soap, rinse with warm water, and gently pat your skin dry. Then apply the gel...
- Yes — your pharmacist mixes this gel before dispensing it, and once it's mixed it must be kept in the refrigerator. Don't freeze it. It also has a 3-month expiration date from the...
- The most common ones are skin dryness, peeling, redness, itching, or a mild burning sensation where you apply it. These are usually mild. If you notice hives or more serious skin i...
🕸️ Concept Web — How Benzoyl peroxide 0.05 MG/MG / erythromycin 0.03... Connects
RxCUI 244374 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Benzoyl peroxide
1418IN -
Erythromycin
4053IN -
Benzoyl peroxide / erythromycin
392556MIN
-
Benzoyl peroxide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Benzamycin
117919BN
-
Benzamycin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Benzoyl peroxide / erythromycin Topical Gel
377970SCDF -
Benzoyl peroxide / erythromycin Topical Product
1152980SCDG -
Benzoyl peroxide / erythromycin Topical Gel [Benzamycin]
108358SBDF -
Benzamycin Topical Product
1172196SBDG -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Benzoyl peroxide / erythromycin Topical Gel
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Benzoyl peroxide 0.05 MG/MG
328718SCDC -
Erythromycin 0.03 MG/MG
329378SCDC -
Benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]
213082SBD -
Benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG [Benzamycin]
573012SBDC
-
Benzoyl peroxide 0.05 MG/MG
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
Benzoyl peroxide 0.05 MG/MG
SCDC · 328718 -
Erythromycin 0.03 MG/MG
SCDC · 329378 -
Benzoyl peroxide / erythromycin Topical Gel
SCDF · 377970 -
Benzoyl peroxide / erythromycin Topical Product
SCDG · 1152980
Brand-Name Concepts
-
Benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Benzamycin]
SBD · 213082 -
Benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG [Benzamycin]
SBDC · 573012 -
Benzoyl peroxide / erythromycin Topical Gel [Benzamycin]
SBDF · 108358 -
Benzamycin Topical Product
SBDG · 1172196 -
Benzamycin
BN · 117919
📦 FDA Products & Package NDCs
4 products · 5 package NDCs
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00187-5205-46 | 1 KIT in 1 BOX (0187-5205-46) * 1.6 g in 1 VIAL, PLASTIC *... | Benzamycin | Bausch Health US, LLC | 1984-10-26 |
| 64980-0328-01 | 23.3 g in 1 JAR (64980-328-01) | Erythromycin and Benzoyl Peroxide | Rising Pharma Holdings, Inc. | 2016-10-18 |
| 64980-0328-02 | 46.6 g in 1 JAR (64980-328-02) | Erythromycin and Benzoyl Peroxide | Rising Pharma Holdings, Inc. | 2016-10-18 |
| 68682-0900-23 | 1 KIT in 1 CARTON (68682-900-23) * .8 g in 1 VIAL, PLASTIC... | Erythromycin and Benzoyl Peroxide | Oceanside Pharmaceuticals | 1984-10-26 |
| 68682-0901-46 | 1 KIT in 1 CARTON (68682-901-46) * 40 g in 1 JAR (68682-92... | Erythromycin and Benzoyl Peroxide | Oceanside Pharmaceuticals | 1984-10-26 |
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.